| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258
http://www.zacks.com/stock/news/730536/jazz-jazz-submits-nda-for-xyrem-follow-on-candidate-jzp-258?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-730536
Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
0
Why Long-Term Investors Should Avoid TEVA Stock Like the Plague
https://www.fool.com/investing/2020/01/22/why-long-term-investors-should-avoid-teva-stock-li.aspx?source=iedfolrf0000001
Jan 22, 2020 - Strapped with debt and battling legal controversies right and left, Teva’s best days could very well be behind it.
0
Why You Should Still Buy Teva
https://seekingalpha.com/article/4318277-why-you-should-still-buy-teva?source=feed_tag_israel
Jan 22, 2020 - Teva is set to hold the $10 support line.Company's restructuring and debt reduction on schedule.Future growth in place with two products leading it.
0
Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe
http://www.zacks.com/stock/news/728495/novartis-nvs-gets-approval-for-ms-drug-mayzent-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-728495
Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
0
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Approval in Europe
http://www.zacks.com/stock/news/727955/jazzs-jazz-new-sleep-drug-sunosi-gets-approval-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-727955
Jan 21, 2020 - Jazz (JAZZ) receives approval for Sunosi as a treatment for excessive daytime sleepiness in narcolepsy or obstructive sleep apnea patients in Europe.
0
Teva Pharmaceutical (TEVA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
https://seekingalpha.com/article/4316745-teva-pharmaceutical-teva-presents-38th-annual-j-p-morgan-healthcare-conference-slideshow?source=feed_tag_israel
Jan 14, 2020 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with this event.
0
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript)
https://seekingalpha.com/article/4316595-teva-pharmaceutical-industries-limited-teva-ceo-kare-schultz-on-38th-annual-jp-morgan?source=feed_tag_israel
Jan 13, 2020 - Teva Pharmaceutical Industries Limited (NYSE:TEVA) 38th Annual JP Morgan Healthcare Conference January 13, 2020 01:30 PM ET Company Participants Kåre Schultz - President and Chief Executive Officer Co
0
Teva to pay $54M to settle suit over sham programs to boost drug sales
https://seekingalpha.com/news/3529875-teva-to-pay-54m-to-settle-suit-over-sham-programs-to-boost-drug-sales?utm_source=feed_news_all&utm_medium=referral
Jan 06, 2020 - The attorney representing two former sales reps at Teva Pharmaceutical Industries (TEVA -0.8%) announces that the company has agreed to pay $54M to settle allegations that it used sham paid speaker pr
0
My Top Portfolio Holdings for 2020
https://www.fool.com/investing/2019/12/30/my-top-portfolio-holdings-for-2020.aspx?source=iedfolrf0000001
Dec 30, 2019 - These four stocks will hopefully be bringing home the bacon in the new year.
0
Migraine sufferers have new oral medication with FDA approval of Allergan's Ubrelvy
https://www.cnbc.com/2019/12/26/migraine-sufferers-have-new-tool-with-approval-of-allergans-ubrelvy.html
Dec 26, 2019 - Ubrelvy is proven to ease migraine symptoms in two hours.
0
Page 1>